These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5315082)

  • 1. Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure.
    Elsas LJ; Hayslett JP; Spargo BH; Durant JL; Rosenberg LE
    Ann Intern Med; 1971 Sep; 75(3):427-33. PubMed ID: 5315082
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal clearances of different amino acids in Wilson's disease before and after treatment with penicillamine.
    Schonheyder F; Gregersen G; Hansen HE; Skov PE
    Acta Med Scand; 1971 Nov; 190(5):395-9. PubMed ID: 5149266
    [No Abstract]   [Full Text] [Related]  

  • 3. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
    López-Guerra N; Alvarez Lario B; García-Moncó C; Peña Sagredo JL
    Med Clin (Barc); 1987 Apr; 88(13):552-4. PubMed ID: 3586738
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotic syndrome in the course of treatment of Wilson's disease with DL-penicillamine.
    Karp M; Lurie M; Yonis Z
    Arch Dis Child; 1966 Dec; 41(220):684-7. PubMed ID: 5927925
    [No Abstract]   [Full Text] [Related]  

  • 7. Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities?
    Dell'era L; Boati E; Nebbia G; Corona F
    Minerva Pediatr; 2012 Feb; 64(1):55-7. PubMed ID: 22350045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal function disorders in congenital metabolic abnormalities. 1. Renal function disorders in Wilson's disease].
    Ito K
    Nihon Shonika Gakkai Zasshi; 1971 Jun; 75(6):454-63. PubMed ID: 5104632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
    Gregersen G; Frederiksen G
    Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040
    [No Abstract]   [Full Text] [Related]  

  • 10. D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson's disease.
    Lee Y; Lee ST; Cho H
    Clin Nephrol; 2016 May; 85(5):296-300. PubMed ID: 26784915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature.
    Ntoso KA; Tomaszewski JE; Jimenez SA; Neilson EG
    Am J Kidney Dis; 1986 Sep; 8(3):159-63. PubMed ID: 3752071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria and other renal functions in Wilson's disease.
    Sözeri E; Feist D; Ruder H; Schärer K
    Pediatr Nephrol; 1997 Jun; 11(3):307-11. PubMed ID: 9203178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lupus erythematosus due to penicillamine associated with Wilson's disease].
    Boudin G; Pépin B; Godeau P; Vernant JC; Gouerou H
    Ann Med Interne (Paris); 1971 Feb; 122(2):269-73. PubMed ID: 5579428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson's disease].
    Farallo M; Amoruso C; Frattini C; Ardissino G; Nebbia G
    Pediatr Med Chir; 2012; 34(5):234-6. PubMed ID: 23342748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A syndrome similar to systemic lupus erythematosus caused by penicillamine in patients with Wilson's disease].
    Kalina P; Procházková L; Hauftová D
    Bratisl Lek Listy; 1985 Sep; 84(3):336-40. PubMed ID: 4041939
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serious side effects with D-penicillamine therapy for Wilson's disease].
    Storch W; Lössner J; Ruchholtz U
    Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):531-8. PubMed ID: 161403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case.
    Toaff R; Toaff ME; Peyser MR; Streifler M
    Obstet Gynecol Surv; 1977 Aug; 32(8):497-507. PubMed ID: 331163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillamine for tubular dysfunction in Wilson's disease.
    Troelstra JA; Holl H
    Lancet; 1968 May; 1(7551):1094. PubMed ID: 4171778
    [No Abstract]   [Full Text] [Related]  

  • 19. [Functional disorders of the renal tubules in Wilson's disease].
    Holl H; Troelstra JA
    Ned Tijdschr Geneeskd; 1968 Nov; 112(48):2184-8. PubMed ID: 5704622
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review.
    Shi W; Huang X; Zhang S; Jiao Y
    Clin Rheumatol; 2021 Jun; 40(6):2485-2490. PubMed ID: 33057918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.